Identification of paediatric cancer patients with poor quality of life by Sung, L et al.
Identification of paediatric cancer patients with poor quality of life
L Sung*,1,6, RJ Klaassen
2, D Dix
3,4, S Pritchard
3,4, R Yanofsky
5, B Dzolganovski
6, R Almeida
6 and A Klassen
7
1Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G 1X8, Canada;
2Department of Pediatrics,
Children’s Hospital of Eastern Ontario, 401 Smyth, Ottawa, ON, K1H 8L1, Canada;
3Department of Pediatrics, University of British Columbia, A119D,
4480 Oak Street, Vancouver, BC, V6H 4C9, Canada;
4Department of Pediatrics, University of British Columbia, A123D, 4480 Oak Street, Vancouver,
BC, V6H 3V4, Canada;
5Department of Pediatrics and Child Health, University of Manitoba, 675 McDermot Avenue, Winnipeg, MB, R3E 0V9,
Canada;
6Child Health Evaluation Sciences, The Hospital for Sick Children, 424, 123 Edward Street, Toronto, ON, M5G 1E2, Canada;
7Department
of Pediatrics, McMaster University, HSC 3N27, 1200 Main Street West, Hamilton, ON, L8S 4J9, Canada
The primary objective was to describe predictors of physical, emotional and social quality of life (QoL) in children receiving active
treatment for cancer. This Canadian multi-institutional cross-sectional study included children with cancer receiving any type of active
treatment. The primary caregiver provided information on child physical, emotional and social QoL according to the PedsQL 4.0
Generic Core scales. Between November 2004 and February 2007, 376 families provided the data. In multiple regression, children
with acute lymphoblastic leukemia had better physical health (OR: 0.37, 95% CI 0.23, 0.60; Po0.0001) while intensive chemotherapy
treatment (OR: 2.34, 95% CI: 1.42, 3.85; P¼0.0008) and having a sibling with a chronic condition (OR: 2.53, 95% CI: 1.54, 4.15;
P¼0.0002) were associated with poor physical QoL. Better emotional health was associated with good prognosis, less intensive
chemotherapy treatment and greater household savings, whereas female children and those with a sibling with a chronic condition
had poor social QoL. Physical, emotional and social QoL are influenced by demographic, diagnostic and treatment variables. Sibling
and household characteristics are associated with QoL. This information will help to identify children at higher risk of poor QoL
during treatment for cancer.
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Measurement of quality of life (QoL) in paediatric cancer patients
is becoming increasingly emphasized in clinical trials. This
outcome is important as it provides a measure of well-being from
the perspective of the parent or child. To date, most QoL research
in paediatric cancer has been directed towards the development of
reliable and valid instruments and describing expected QoL in this
population. Ultimately, better understanding of QoL in children
with cancer may be useful for several reasons. This knowledge may
help parents and children anticipate the expected course of events
during treatment. In addition, measurement of QoL may help
families and healthcare professionals choose specific treatment
strategies, if these strategies are associated with similar survival
rates but different expected QoL. Another goal, though, may be to
identify a group of children with expected poor QoL such that they
could be targeted for supportive care interventions to improve
their health.
There are many challenges to measuring QoL in children. First is
the issue of self-report vs proxy report. Although self-report is the
usual method for assessing QoL, this method is not always feasible
or possible for children with health conditions who may be too ill,
unwilling or lacking the necessary language skills, attention span
or cognitive abilities to complete questionnaires themselves.
Paediatric cancer patients are often very young, which emphasises
difficulty with self-report. Proxies, usually the parent, may need to
provide information on their behalf (Matza et al, 2004; Eiser and
Jenney, 2007). Eiser and Morse (Eiser and Morse, 2001a,b) have
systematically reviewed parent proxy and child self-report of QoL
and found that parents and children typically agreed upon more
observable phenomenon, such as the level of physical activity,
functioning and symptoms. Conversely, poor agreement was seen
in more subjective areas, such as social or emotional functioning
(Eiser and Morse, 2001a,b). Although parent and child responses
may differ, others have emphasised that parent perspectives are
important and valid perspectives of the child’s QoL (Matza et al,
2004; Pickard et al, 2004; Eiser and Jenney, 2007). As parents are
often the primary reporters of symptoms and are the main
decision-makers on behalf of their child, their evaluation of QoL is
clinically relevant, when used in a complementary manner to child
self-report when obtainable (Matza et al, 2004; Pickard et al, 2004;
Eiser and Jenney, 2007).
Second, choosing a specific instrument to measure QoL in a
study is challenging. In general, generic and disease-specific
instruments are available (Guyatt et al, 1993). Disease-specific
measures may be most useful when responsiveness and sensitivity
are important. However, generic instruments also are important as
there are normative reference data and their use permits compa-
rison across different patient populations (Spieth and Harris, 1996).
For our purpose, the PedsQL generic module represented a
Received 30 May 2008; revised 11 November 2008; accepted 21
November 2008; published online 9 December 2008
*Correspondence: Dr L Sung; E-mail: Lillian.sung@sickkids.ca
British Journal of Cancer (2009) 100, 82–88
& 2009 Cancer Research UK All rights reserved 0007– 0920/09 $32.00
www.bjcancer.com
C
l
i
n
i
c
a
l
S
t
u
d
i
e
sparticularly attractive generic measure as it has been widely used in
children with cancer and there are enough normative data and
previous experience to allow us to delineate a group with particularly
poor QoL.
Most of the literature attempting to predict QoL in children with
cancer has focused on late effects of cancer. However, QoL during
active treatment also is important to children and their families.
Studies of children receiving active treatment primarily have
consisted of small studies that did not identify those at high risk of
poor outcomes (Nathan et al, 2004). Consequently, the primary
objective of this report was to describe predictors of physical,
emotional and social QoL in children receiving chemotherapy for
cancer. The secondary objective was to identify children at risk for
particularly poor QoL as defined as physical, emotional and social
QoL that was at least two standard deviations below the mean for a
general paediatric population.
MATERIALS AND METHODS
Patients
This study was a subset of a larger study designed to evaluate
psychosocial health in parents of children receiving chemotherapy
for cancer (Klassen et al, 2008). Children were eligible for inclusion
if they were receiving treatment for any type of malignancy, if they
were initially diagnosed more than 2 months before enrollment on
this study, and if they were not considered palliative as defined as
no reasonable chance for cure by their healthcare team. In
addition, children were only eligible if the parent respondent was
the person most responsible for the day-to-day decision-making
for that child for the past year and the parent respondent could
read English. Children were enrolled from five tertiary care
Canadian paediatric cancer centres as follows: BC’s Children’s
Hospital (Vancouver), CancerCare Manitoba (Winnipeg), Chil-
dren’s Hospital of Eastern Ontario (Ottawa), The Hospital for Sick
Children (Toronto) and McMaster Children’s Hospital (Hamilton).
Methods
Patients were approached for participation either in the in-patient
or outpatient settings in a consecutive fashion. The family was
given a booklet to complete in which questions about the child’s
QoL were asked (see Outcomes below). The booklet also contained
questions about child, parent and family characteristics. The
completed booklet was returned to the team in person or by mail.
Child variables included demographic information, and informa-
tion on diagnosis, treatment and parent-reported prognosis (very
good or excellent vs good, fair or poor). We asked parents about
the intensity of treatment, which was scored on a 5-point rating
scale (more intensive (4 or 5) vs less intensive (1–3)). Both the
prognosis and intensity of treatment scales were developed for this
study. We also asked whether the child had a chronic condition
other than cancer. Parent variables included demographics,
highest education of the primary caregiver and their spouse,
employment and marital status and whether the primary caregiver
had a chronic condition. Family variables included whether a
sibling had a chronic condition, household income and savings.
Categorisation for chronic conditions in children and adults was
derived from those used in the National Longitudinal Survey of
Children and Youth (NLSCY; Statistics Canada, 2002). The NLSCY
is a long-term study conducted by Statistics Canada, which follows
the development and well-being of Canadian children from birth to
early adulthood. Household income was recoded into above and
below $60000 annually (approximate median value in this sample).
We also computed adjusted family income, a measure of income
that adjusts for family size and composition that accounts for the
benefits of multiple wage earners in the family as well as the
economy of multiple individuals living in a single household
compared with per capita income (Carson, 2002).
In addition to the data provided by parents, diagnosis and
treatment information were abstracted from hospital charts by
institutional clinical research associates. Institutional research
ethics approval was obtained from each of the participating centers
and written informed consent was obtained from all participants.
Outcomes
The PedsQL is a multidimensional instrument that is reliable and
valid in healthy populations and in children with cancer (Varni.
et al, 1998a,b, 1999a,b, 2001, 2002). This instrument is composed
of a 23-item PedsQL 4.0 Generic Core scale that reflects four
dimensions, namely physical, emotional, social and school
functionings. In general, the summary scores available from the
PedsQL are psychosocial and physical scores, with psychosocial
scores consisting of emotional, social and school dimensions.
Because children on cancer chemotherapy often do not attend
school, we could not assess the school domain for the majority of
children, and consequently, we did not determine the psychosocial
summary score. Thus, the outcomes for this study were the
physical, emotional and social summary scores of the PedsQL 4.0
Generic Core Scales. A 1-month recall period was used.
We examined dimension scores in two ways. First, to determine
what factors were associated with the three dimension scores, we
examined the scores as continuous variables, which maximized the
ability to identify predictors of these outcomes assuming that the
relationship between the predictors and outcomes was linear. We
presented these associations as b-coefficients with their standard
errors as derived from linear regression. Positive b-coefficients
meant that the predictor (or increasing values of the predictor) was
associated with better QoL, whereas negative b-coefficients
suggested that the predictor (or increasing values of the predictor)
was associated with worse QoL. Second, we also wanted to
determine predictors of clinically significant impairment of
physical, emotional and social QoL. Varni et al (2003) previously
explored the cutoff points for ‘at-risk status’ for impaired QoL and
determined in a large paediatric population, that one standard
deviation below the mean of the total population sample was a
clinically meaningful measure of impaired QoL as it represented
scores similar to children with severe chronic health condition.
However, because our population consisted of children with a
chronic health condition (namely cancer), we defined low QoL as a
score of two standard deviations below the population mean;
(Varni et al, 2003); these values were derived using data from a
PedsQL database (Varni et al, 2007b).
To see whether the model could distinguish between children
with and without poor physical, emotion and social QoL, we
compared items from the PedsQL 3.0 Acute Cancer Module for
these 2 groups and based on clinical experience, hypothesized that
those who were at high risk for poor physical health should have
worse pain and hurt scores, those at high risk for poor emotional
health should have worse pain and hurt, nausea, anxiety, worry
and cognition scores and those at high risk for poor social health
should have worse scores on the communication and cognition
domains.
Statistics
Potential predictors of physical, emotional and social scores were
determined using univariate linear or logistic regression analyses
depending on whether the outcome was QoL as a continuous or
dichotomous variable. For multiple regression modelling, factors
that were associated with QoL at Po0.1 were entered into a
forward selection model. All statistical analyses were performed
using the SAS statistical program (SAS-PC, version 9.1; SAS
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sInstitute Inc., Cary, NC). All tests of significance were two-sided,
and statistical significance was defined as Po0.05.
RESULTS
Subjects were enrolled between November 2004 and February
2007. A total of 513 parents were asked to participate in this study
and 501 agreed. We received completed questionnaires back from
412 parents, giving an overall response rate of 80.3%. We excluded
data for one parent who answered the questionnaire retro-
spectively, leaving a sample size of 411. Of these 411, 376 had
children who were at least 2 years of age and could complete the
PedsQL assessment. Parent and child characteristics appear in
Table 1. Of the 376 children, 275 (73.1%) had leukemia or
lymphoma and most children had acute lymphoblastic leukemia
(ALL; 214/376, 56.9%). The remaining children had a solid tumour
(55/376, 14.6%) or a brain tumour (35/376, 9.3%). Disseminated
disease was present in 27/376 (7.2%) of the entire cohort and was
present in 17/55 (30.9%) of those with solid tumours. The majority
of parents rated their child’s prognosis as very good or excellent
(293/376; 77.9%). The most common chronic conditions reported
for parents were anxiety (65/376; 17.3%), respiratory allergies
(62/376; 16.5%) and depression (57/376; 15.2%). The most
common chronic conditions reported for siblings were non-food
allergies (35/376; 9.3%), mental handicap (13/376; 3.5%) and heart
problems (10/376; 2.7%).
The mean summary score for physical function was 54.9 (95%
CI: 9.4, 96.9; N¼374), which was 28.4 points lower than the mean
physical function score of 83.3 found in a large statewide pediatric
survey in which QoL was assessed in 10241 families (Varni et al,
2003). Similarly, the mean summary scores for emotional QoL was
61.1 (95% CI: 25, 95; N¼376), which was 19.2 points lower than
the mean emotional score of 80.3 in the statewide survey (Varni
et al, 2003), and the mean summary scores for social QoL was 69.7
(95% CI: 35, 100; N¼372), which was 12.5 points lower than the
mean social score of 82.2 in the statewide survey (Varni et al,
2003). In our study, poor QoL was defined as QoL that was at least
two standard deviations below the mean for a general paediatric
population. Two standard deviations below the population mean
varied by child age, but this value ranged from 36.82 to 61.59 for
physical function, whereas the value ranged from 41.42 to 56.82 for
emotional scores and 32.07 to 60.63 for social scores (Varni et al,
2007b). The number of children with particularly poor physical,
emotion and social QoL as defined as scores at least two standard
deviations below the population mean were 143/374 (38.2%), 94/
376 (25%) and 51/372 (13.7%), respectively.
Table 2 illustrates that the child factors associated with better
physical health were younger child age, ALL, better parent-rated
prognosis, absence of radiotherapy or surgery to remove cancer,
less intensive chemotherapy treatment and absence of other child
chronic conditions. Parent factors that were associated with better
child physical health were younger parent age, and the absence of a
chronic condition in the parent. Finally, if the sibling had a chronic
condition, then the child’s physical health was worse. Tables 2 also
illustrates the factors that were associated with emotional and
social QoL in univariate linear regression.
In examining multiple regression models, only child age was
included if both child age and parent age met criteria for inclusion
into the model because they were highly correlated (Spearman
r¼0.61; Po0.0001). Similarly, if both ALL and any surgery to
remove cancer met criteria for inclusion in the multiple regression
model, only ALL was included because they were highly negatively
correlated (Spearman r¼ 0.61; Po0.0001). Finally, in terms of
family factors, if both adjusted income and savings of at least
$10000 both met criteria to be included in multiple regression,
only adjusted income was used as they were highly correlated
(Spearman r¼0.52; Po0.0001).
Variables that were independently associated with physical,
emotional and social QoL appear in Table 3. Older child age and
more intensive chemotherapy treatment both were independently
associated with worse physical, emotional and social functions.
Interestingly, if the child’s parents reported that the sibling or
parent had a chronic condition, this occurrence was associated
with worse function in the child with cancer; those with a parent
with a chronic condition has worse physical and emotional
functions, whereas those with a sibling with a chronic condition
had worse physical and social functions.
Tables 4 and 5 illustrate logistic regression analyses to examine
predictors of poor physical, emotional and social QoL as defined as
having a score less than two standard deviations below the
population mean. In multiple logistic regression analyses, a
diagnosis of ALL independently predicted for better physical
function, whereas those receiving intensive chemotherapy treat-
ment as perceived by the parent, and those with a sibling with a
chronic condition had a two- to three-fold increased odds for poor
physical QoL (Table 5). In terms of emotional QoL, those with a
parent-rated prognosis of very good or excellent and those with
savings of at least $10000 had better emotional function, whereas
those receiving intensive chemotherapy treatment were at an
almost five-fold increased odds of poor emotional function.
Table 1 Demographics of study population
Variable N
a Value
Child factors
Age, no. (%) 376
2–4 years 110 (29.3)
5–7 years 87 (23.1)
8–12 years 84 (22.3)
X13 years 95 (25.3)
Median years since diagnosis (IQR) 376 0.6 (0.3, 1.3)
Male (%) 376 215 (57.2)
Cancer diagnosis, no. (%) 376
Leukemia 233 (62.0)
Lymphoma 42 (11.2)
Neuroblastoma 19 (5.1)
Sarcoma 36 (9.6)
Brain 35 (9.3)
Other 11 (2.9)
No. acute lymphoblastic leukemia (%) 375 214 (57.1)
No. acute myeloid leukemia (%) 376 13 (3.5)
No. relapse (%) 376 31 (8.2)
No. prognosis of very good or excellent (%) 363 293 (80.7)
No. received radiation (%) 376 82 (21.8)
No. received any surgery to remove
cancer (%)
376 79 (21.0)
No. received SCT (%) 376 30 (8.0)
No. intensive chemotherapy treatment (%) 370 110 (29.7)
No. received alternative treatment (%) 374 32 (8.6)
Parent factors
Median parent age in years (range) 368 39.1 (20.2, 75.9)
No. male (%) 375 47 (12.5)
No. first parenting experience (%) 369 168 (45.5)
No. smoke (%) 376 67 (17.8)
No. university degree (%) 376 120 (31.9)
No. working (%) 371 163 (43.9)
No. chronic condition (%) 376 215 (57.2)
No. married (%) 376 311 (82.7)
Household factors
No. sibling with chronic condition (%) 376 110 (29.3)
No. annual household income X$60000 (%) 354 182 (51.4)
Median adjusted household income in
dollars (IQR)
349 28846 (17500, 42500)
No. savings X$10000 (%) 330 164 (49.7)
IQR¼interquartile range.
aThe total sample size of 376; some respondents did not
complete all questions.
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condition increased the odds of poor social function (Table 5).
Table 6 shows that groups predicted to be at high risk for poor
physical, emotional and social QoL according to the multiple
regression models had worse scores on the PedsQL acute cancer
module domains hypothesized to be associated with physical,
emotion and social health.
DISCUSSION
We determined variables independently associated with physical,
emotional and social QoL in children receiving active treatment for
cancer. In addition, we were able to delineate a group of children at
particularly high risk of poor QoL as defined as two standard
deviations below the mean score for healthy children. As expected,
when QoL was examined as a continuous (rather than dichot-
omous) variable, regression analyses yielded a greater number of
significant predictors of QoL. This information is helpful for
gaining insight into what factors impact on QoL for children with
cancer.
However, predicting low QoL probably is clinically more
relevant to identify high-risk children who may be targeted for
future supportive care interventions. We found that children with
ALL had better physical function, whereas those whose parents
reported more intensive chemotherapy treatment and those with
siblings with a chronic condition had poorer physical QoL. Parent
self-reported worse prognosis, more intensive chemotherapy
treatment and smaller household savings all predicted worse
emotional function. Finally, being female and having a sibling with
a chronic condition predicted for poor social function.
Table 2 Univariate predictors of summary physical, emotional and social dimension scores
a
Physical summary score Emotional summary score Social summary scores
Variable b±s.e.
b P-value b±s.e.
b P-value b±s.e.
b P-value
Child factors
Age in years  1.74±0.26 o0.0001  0.85±0.21 o0.0001  0.91±0.22 o0.0001
Time since diagnosis  0.70±0.98 0.48 0. 00±0.80 1.00  2.53±0.83 0.003
Male 3.75±2.66 0.16 3.80±2.09 0.07 5.14±2.14 0.02
Acute lymphoblastic leukemia 13.28±2.57 o0.0001 5.83±2.08 0.005 5. 66±2.15 0.009
Relapse  5.03±4.70 0.29  1.73±3.78 0.65  10.35±3.89 0.008
Prognosis of very good or excellent 10.73±3.36 0.002 10.73±2.63 o0.0001 10.10±2.70 0.0002
Radiation  9.41±3.15 0.003  4.02±2.51 0.11  4.42±2.60 0.09
Surgery to remove cancer  14.61±3.14 o0.0001  3.84±2.55 0.13  7.01±2.60 0.008
Stem cell transplant  7.57±4.83 0.12  0.83±3.84 0.83  6.25±3.92 0.11
Intensive chemotherapy treatment  15.06±2.79 o0.0001  12.96±2.18 o0.0001  7.65±2.32 0.001
Alternative treatment  3.55±4.63 0.44  7.90±3.72 0.03  7.23±3.79 0.06
Other chronic condition  9.46±3.44 0.006  6.72±2.73 0.01  3.27±2.81 0.25
Parent factors
Age in years  0.66±0.19 0.0006  0.16±0.15 0.31  0.19±0.16 0.23
Male 3.00±3.98 0.45 7.02±3.13 0.03 2.68±3.22 0.41
Smoke  4.67±3.45 0.18  4.20±2.71 0.12  4.21±2.79 0.13
University Education 4.37±2.81 0.12 1.63±2.23 0.47 4.55±2.28 0.05
Working 4. 23±2.67 0.11 4. 32±2.10 0.04 5.63±2.15 0.009
Chronic condition  10.14±2.61 0.0001  9.13±2.05 o0.0001  8.68±2.11 o0.0001
Married 6.02±3.46 0.08 5. 84±2.74 0.03 7.14±2.79 0.01
Household factors
Sibling with chronic condition  11.30±2.83 o0.0001  4.19±2.28 0.07  8.57±2.32 0.0002
Annual household income X$60000 2.18±2.69 0.42  1.25±2.13 0.56 5.24±2.20 0.02
Adjusted household income 0.00±0.00 0.30 0.00±0.00 0.86 0.00±0.00 0.006
Savings X$10000 1.11±2.78 0.69 0.83±2.17 0.70 4.30±2.20 0.05
s.e.¼standard error.
aMean summary scores are presented in the Results.
bb-Coefficient from univariate linear regression. Positive b-coefficients meant that the predictor (or
increasing values of the predictor) was associated with better quality of life, whereas negative b-coefficients suggested that the predictor (or increasing values of the predictor)
was associated with worse quality of life.
Table 3 Multiple linear regression for physical, emotional and social
summary scores
a
Variable b±s.e.
b P-value
Physical summary score
Age of the child  1.37±0.26 o0.0001
Acute lymphoblastic leukemia 5.93±2.50 0.02
Intensive chemotherapy treatment  6.12±0.90 o0.0001
Parent with chronic condition  5.45±2.40 0.02
Sibling with chronic condition  8.52±2.56 0.001
Emotional summary score
Age of the child  0.68±0.19 0.0005
Male child 3.80±1.88 0.04
Prognosis of very good or excellent 7.84±2.38 0.001
Intensive chemotherapy treatment  5.47±0.72 o0.0001
Male parent 6.17±2.82 0.03
Married 4.96±2.50 0.05
Parent with chronic condition  5.29±1.94 0.007
Social summary score
Age of the child  0.94±0.22 o0.0001
Time since diagnosis  3.52±0.94 0.0004
Male child 5.14±2.07 0.01
Intensive chemotherapy treatment  3.93±0.81 o0.0001
Parent working 5.72±2.11 0.01
Sibling with chronic condition  5.90±2.22 0.02
Household adjusted income 0.00±0.00 0.004
s.e.¼standard error.
aMean summary scores are presented in the Results.
bb-coefficient from univariate linear regression, Positive b-coefficients meant that
the predictor (or increasing values of the predictor) was associated with better quality
of life, whereas negative b-coefficients suggested that the predictor (or increasing
values of the predictor) was associated with worse quality of life.
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sOur finding that children with ALL had better physical function
than children with other types of cancers is not surprising and is
consistent with other reports (Meeske et al, 2004; Varni et al,
2007a). It also is clinically intuitive that more intensive
chemotherapy treatment would be associated with worse physical
and emotional functions.
We also found that chronic diseases in the sibling and parent
were associated with the child’s QoL. This influence of parent and
sibling chronic condition on the child’s QoL was consistent among
the different analyses. More specifically, those with a sibling with a
chronic condition had particularly poor physical and social QoL.
Others have shown that parents with poor physical or psychosocial
health have children with poorer QoL in several different
conditions (Silver et al, 1998; Waters et al, 2000; Wagner et al,
2003; Williams et al, 2003). A study in paediatric cancer also found
an association between maternal depression and child self-
reported poor QoL (Vance et al, 2001). We were not able to
identify literature that specifically examined sibling chronic
conditions and paediatric cancer QoL, and thus our finding is
unique.
Several possibilities may explain these associations. First,
there may be a biological explanation; the chronic conditions
may be heritable, and thus may be causative in the child
with cancer’s poor QoL. However, this hypothesis is not supported
by our data as we did not find an association between the
child with cancer having a chronic condition and worse QoL.
Second, it is possible that parents who perceive their own health or
the health of their other children as worse may also perceive that
the child with cancer has worse QoL. Finally, it is possible that
having a sibling with a chronic condition is somehow causative in
poor physical and social QoL related to effects on the home
environment.
A limitation of our study is that we used only parent-reported
QoL. Parent and child report are known to differ, especially for the
psychosocial domains of health (Eiser and Morse, 2001a).
However, in our study, proxy report was necessary as a large
proportion of the sample were too young to provide self-report
data. In addition, others have noted that the multiple different
perspectives of QoL including the parent perspective are all
important and contribute to our understanding of child health
Table 4 Predictors of low physical, emotional and social summary scores
a,b
Physical summary score Emotional summary score Social summary score
Variable OR (95% CI) P-value OR (95% CI) P-value OR (95% CI) P-value
Child factors
Age in years 1.07 (1.02, 1.12) 0.003 0.99 (0.95, 1.04) 0.80 0.99 (0.93, 1.05) 0.77
Time since diagnosis 0.98 (0.84, 1.15) 0.79 0.92 (0.75, 1.12) 0.39 1.16 (0.96, 1.41) 0.12
Male 0.70 (0.46, 1.06) 0.09 1.08 (0.67, 1.73) 0.76 0.44 (0.24, 0.80) 0.008
Acute lymphoblastic leukemia 0.35 (0.23, 0.53) o0.0001 0.77 (0.48, 1.22) 0.26 0.99 (0.54, 1.79) 0.97
Relapse 1.12 (0.53, 2.34) 0.75 0.70 (0.28, 1.77) 0.45 2.06 (0.84, 5.09) 0.12
Prognosis of very good or excellent 0.48 (0.28, 0.82) 0.007 0.34 (0.20, 0.60) 0.0001 0.59 (0.29 1.19) 0.14
Radiation 1.44 (0.88, 2.37) 0.15 1.13 (0.65, 1.97) 0.67 0.76 (0.35, 1.62) 0.47
Any surgery to remove cancer 3.04 (1.83, 5.07) o0.0001 0.78 (0.43, 1.42) 0.42 1.35 (0.68, 2.68) 0.39
Stem cell transplantation 2.26 (1.06, 4.81) 0.03 1.32 (0.58, 2.98) 0.51 1.29 (0.47, 3.53) 0.62
Intensive chemotherapy treatment 2.59 (1.64, 4.10) o0.0001 4.09 (2.49, 6.72) o0.0001 1.76 (0.95, 3.25) 0.07
Alternative treatment 1.20 (0.58, 2.48) 0.62 1.90 (0.89, 4.06) 0.10 1.92 (0.78, 4.71) 0.15
Other chronic condition 1.87 (1.09, 3.20) 0.02 1.18 (0.65, 2.16) 0.58 0.59 (0.24, 1.45) 0.25
Parent factors
Age in years 1.02 (0.99, 1.06) 0.099 0.98 (0.95, 1.02) 0.28 0.97 (0.92, 1.01) 0.14
Male 0.73 (0.38, 1.39) 0.33 0.68 (0.31, 1.46) 0.32 0.39 (0.12, 1.31) 0.13
Smoke 1.44 (0.84, 2.46) 0.18 1.48 (0.83, 2.63) 0.19 0.99 (0.46, 2.15) 0.98
University Education 0.73 (0.47, 1.16) 0.18 0.77 (0.46, 1.28) 0.31 0.97 (0.51, 1.83) 0.92
Working 0.66 (0.43, 1.01) 0.06 0.70 (0.43, 1.14) 0.15 0.50 (0.26, 0.94) 0.03
Chronic condition 1.83 (1.19, 2.82) 0.008 1.97 (1.20, 3.24) 0.007 1.98 (1.04, 3.75) 0.04
Married 0.91 (0.53, 1.58) 0.75 0.59 (0.33, 1.05) 0.07 0.85 (0.40, 1.79) 0.67
Household factors
Sibling with chronic condition 2.35 (1.49, 3.70) 0.0002 1.44 (0.88, 2.37) 0.15 1.88 (1.02, 3.46) 0.04
Annual household income X$60000 0.89 (0.58, 1.37) 0.59 0.70 (0.43, 1.15) 0.16 0.68 (0.37, 1.25) 0.21
Adjusted household income per $100000 1.00 (0.88, 1.14) 0.97 0.90 (0.77, 1.04) 0.15 0.95 (0.79, 1.14) 0.57
Savings X$10000 0.98 (0.63, 1.53) 0.93 0.63 (0.38, 1.06) 0.08 0.78 (0.41, 1.46) 0.44
CI¼confidence interval; OR¼odds ratio.
aMean summary scores are presented in the Results.
bLow is defined as p2s.d. below the mean for a general paediatric population
(see Methods).
Table 5 Multiple logistic regression for low physical, emotional and social
summary scores
a,b
Variable
c OR (95% CI)
a P-value
Physical summary score
Diagnosis of not acute lymphoblastic leukemia 2.67 (1.67, 4.28) o0.0001
Intensive chemotherapy treatment 2.34 (1.42, 3.85) 0.0008
Sibling with chronic condition 2.53 (1.54, 4.15) 0.0002
Emotional summary score
Prognosis of not very good or excellent 2.66 (1.39, 5.11) 0.003
Intensive chemotherapy treatment 4.90 (2.78, 8.64) o0.0001
Less than $10000 of savings 1.77 (1.00, 3.12) 0.0496
Social summary score
Child female 2.27 (1.22, 4.23) 0.01
Sibling with chronic condition 2.12 (1.13, 3.96) 0.02
OR¼odds ratio; CI¼confidence interval.
aMean summary scores are presented in
the Results.
bLow is defined as p2s.d. below the mean for a general paediatric
population (see Methods).
cpotential predictors shown in terms of factors associated
with worse quality of life (e.g., in this table, female child gender is shown rather than
male child gender).
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child self-report to understand whether such an approach results
in fundamentally different high-risk groups compared with parent
proxy respondents. Second, we modelled several different out-
comes, and therefore there is a possibility of chance findings.
These analyses were all conducted as secondary objectives, and
therefore these results must be considered hypothesis generating.
Third, we developed the prognosis and intensity of therapy scales
for this study, and therefore there are no reported data on their
reliability or validity. Finally, as with any study that attempts to
build a prediction model, similar studies in different populations
of children on active treatment for cancer will be critical to
examine model validation and to determine the best variables to
delineate a high-risk population at risk for poor QoL.
The results of this study are important as the majority of QoL
research in paediatric cancer has focused on late effects of cancer
therapy, or examined both children on and off treatment rather
than during active therapy. However, QoL during active treatment
also is important to study and will influence the experiences of the
child and family. We would expect that QoL should be very
different between children receiving active treatment vs those who
have completed treatment, as the treatment period is predomi-
nated by toxicities of therapy and often radical changes in normal
day-to-day routines for the child and family. Conversely, QoL in
survivors would be expected to be mostly influenced by sequelae of
therapy. Both of these perspectives are important and improve-
ment in QoL during both periods should be a priority. Our report
is valuable as it is the largest study to our knowledge focused on
QoL in children receiving active treatment for cancer.
One of the difficulties with trying to measure QoL in children
receiving active treatment for cancer is that symptoms during
chemotherapy often fluctuate greatly depending on when QoL is
assessed relative to when chemotherapy is administered, as well as
the specific treatments provided. This issue is most relevant for
aggressive chemotherapy that is typically administered in cycles
every 2–4 weeks. Our use of a 1-month recall period was an attempt
to try and capture in a summary form the effects of these different
phases of symptoms. However, future research within specific
diagnostic subgroups will be able to better define the contribution of
specific chemotherapy protocols and agents to QoL.
The strengths of our study include that we sampled paediatric
cancer patients from multiple centers, and thus have data that are
generalisable. In addition, we have one of the largest cohorts in
which sufficient clinical covariates were obtained such that we
were able to built prediction models of the child’s QoL. To the best
of our knowledge, this is the first description of defining children
at risk for particularly poor QoL.
This information may be used in different ways. First, we will be
able to use the information on predictors to target specific groups
for interventional supportive care trials. For example, we could
target children receiving more aggressive chemotherapy treat-
ments for interventions to improve their physical and emotional
health. Second, these associations raise new hypotheses about
contributors to the health of children with cancer. For example, the
associations between chronic conditions in the parent and siblings
raise the possibility that health of the family may affect the health
of the child with cancer.
In summary, physical, emotional and social QoL are influenced
by demographic, diagnosis, and treatment variables. In addition,
characteristics of the sibling and household are associated with
QoL. This information can be used to identify children at higher
risk of poor QoL during active treatment for cancer.
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